Media and Press


iMedicor and EP Global Communications Renew Commitment to Serve the Special Needs and Disabilities Community

Alliance Continues the EPLO Joint Venture to Bring Educational Resources to Physicians, Healthcare Providers, Parents, and Children

Nanuet, NY, - Johnstown, PA -, September 24, 2009 - iMedicor (OTCBB: VMCI) formerly Vemics, Inc. and EP Global Communications (EPGL.OB) have announced the renewal of their strategic alliance to produce Continuing Medical Education (CME) and non-accredited education programs for people with special needs and life long chronic disabilities. iMedicor and EP Global Communications have worked together for a number of years and this relationship has generated substantial revenue for both companies while providing a valuable service to the communities they serve.

As part of this renewed alliance, the companies will produce and live web-casting a minimum of five programs scheduled for the November 19 & 20th World Congress on Disabilities Conference in Jacksonville, FL. Each of these programs has been supported in part by major organizations and associations serving people with special needs including Southwest Airlines, TriCare West; Integratied Hyperbaric Oxygen Centers of Wisconsin and California; Oxyhealth; Valeant Pharmaceuticals; Cybernonics, Inc.; The Cleveland Clinic. See www.wcdexpo.com/conference

The programs currently scheduled for live web-cast include:

  • Keynote Address - Gen. James T. Conway, 34th Commandant Of the U.S. Marine Corps.
  • Lennox Gasteau Syndrome, a Severe Form of Epilepsy - Blanca Vazquez, MD, NYU Medical School.
  • Seizures & Seizure Management: Confirming Diagnosis and Assessing Treatment - Steve Wolf, MD, Beth Israel Medical Center, NY, and Patti McGoldrick, RN, Beth Israel Medical Center, NY.
  • Seizures & Seizure Management: Brain Mapping & Surgical Intervention - Saadhi Ghatan, MD, Columbia University College of Physicians & Surgeons, NY, Patti McGoldrick, RN, Beth Israel Medical Center, NY, and Steve Wolf, MD, Beth Israel Medical Center, NY.
  • Hyperbaric Oxygen Therapy - Its Efficacy and Safety in the Treatment of Cerebral Palsy, Autism, and Traumatic Brain Injury - Pauline Filipek, MD, University of Texas Medical School at Houston, TX, Daniel A. Rossignol, MD, International Child Development Resource Center, FL, James Jeffrey Bradstreet, MD, International Child Development Resource Center, FL, Moderated by Rick Rader, MD, Morton J. Kent Habilitation Center, TN.
Each of these programs will be available to those who cannot attend the WCD Conference in Jacksonville including families and professionals on military bases around the world. In addition, complete video transcripts of the seminars will be stored on www.epliveonline.com, www.EParent.com and www.imedicor.com for future access for a period of 90 days following the end of the conference.

The WCD Conference, now in its 10th year, is one of the premier events serving the special needs community.

About EP Global Communications

EP Global Communications, Inc., parent company of Exceptional Parent (EP) magazine, is a 38-year-old, award-winning, multi-faceted publishing and communications company, which provides timely and indispensable resources and information to families and professionals caring for the needs of children and adults with disabilities. More information on EP Global Communications is available at www.eparent.com.

About iMedicor:

iMedicor is the only HIPAA-compliant solution for interoperable health information transfer that is offered at no cost to physicians, healthcare providers and patients. The iMedicor portal enables disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; pharmaceutical companies to deliver customized educational marketing programs to more than 730,000 healthcare providers nationwide in a highly targeted, non-intrusive manner; and allows a medical practice to send and receive medical records, files and images. For more information on iMedicor visit www.imedicor.com.





The statements contained herein, other than historical information, are or may be deemed to be forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance of iMedicor’s products and services; the nonexclusive and terminable-at-will nature of certain of the company's partnerships and agreements; rapid technological change affecting demand for our products and services; competition from companies providing similar products and services, availability of sufficient financial resources to enable us to expand our operations, as well as other risks detailed from time to time in our filing s with the Securities and Exchange Commission.